Reaction
Medulloblastoma reporting signals
As of the last recalculation, Medulloblastoma appears in 148 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is THIOTEPA (PRR 174.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Thiotepa | 11 | 174.9 | 175.1 |
| Vismodegib | 6 | 98.8 | 98.8 |
| Thalidomide | 20 | 88.4 | 88.5 |
| Etoposide | 35 | 87.4 | 87.4 |
| Temozolomide | 9 | 63.9 | 63.9 |
| Somatropin | 25 | 57.4 | 57.4 |
| Irinotecan Hydrochloride | 5 | 56.6 | 56.6 |